🔗 Visit the ClinicalTrials.gov page for NCT00484406
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. | J Clin Invest | 1994 | 7.25 |
| 2 | Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. | Circulation | 1999 | 1.09 |
| 3 | MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. | Arterioscler Thromb Vasc Biol | 2006 | 0.88 |
| 4 | Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase functional polymorphisms. | Atherosclerosis | 2010 | 0.87 |
| 5 | Matrix metalloproteinase3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. | Atherosclerosis | 2004 | 0.83 |